Hope for patients with Drug-Induced movement disorder

NCT ID NCT01543321

Completed Symptom relief Sponsor: Centre Hospitalier Universitaire, Amiens Source: ClinicalTrials.gov ↗

Summary

This study tested whether the medication tetrabenazine could reduce involuntary movements in people with tardive dyskinesia—a side effect caused by long-term antipsychotic use. Fifty-four adult patients were randomly assigned to receive either tetrabenazine or a placebo pill for 10 weeks to compare effectiveness. Researchers measured changes in movement symptoms and quality of life to determine if this treatment could help manage this often permanent condition.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

AP-HM Hopital de la Timone

Marseille, 13385, France
CH Aix en Provence

Aix-en-Provence, 13100, France
CH des Charpennes

Lyon, 69100, France
CHRU Lille

Lille, 59037, France
CHRU de Nimes

Nîmes, 30900, France
CHU Amiens

Amiens, Picardie, 80000, France
CHU Bordeaux

Bordeaux, 33076, France
CHU Caen

Caen, 14033, France
CHU Clermont-Ferrand

Clermont-Ferrand, 63003, France
CHU Limoges

Limoges, 87042, France
CHU Montpellier

Montpellier, 34295, France
CHU Nantes

Nantes, 44093, France
CHU Nice

Nice, 06002, France
CHU Poitiers

Poitiers, 86021, France
CHU Rouen

Rouen, 76031, France
CHU Saint Antoine

Paris, 75012, France
CHU Strasbourg

Strasbourg, 67091, France
CHU Toulouse

Toulouse, 31059, France
CHU de Rennes

Rennes, 35033, France

Conditions

Explore the condition pages connected to this study.

TARDIVE DYSKINESIA